Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).

Autor: Kunz PL; Yale School of Medicine, New Haven, CT., Graham NT; Dana-Farber Cancer Institute, Boston, MA., Catalano PJ; Dana-Farber Cancer Institute, Boston, MA., Nimeiri HS; Robert H. Lurie Cancer Center of Northwestern University, Chicago, IL., Fisher GA; Stanford University School of Medicine, Stanford, CA., Longacre TA; Stanford University School of Medicine, Stanford, CA., Suarez CJ; Stanford University School of Medicine, Stanford, CA., Martin BA; University of Louisville, Louisville, KY., Yao JC; University of Texas MD Anderson Cancer Center, Houston, TX., Kulke MH; Boston University/Boston Medical Center, Boston, MA., Hendifar AE; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA., Shanks JC; Health East Cancer Care, Lake Elmo, MN., Shah MH; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Zalupski MM; University of Michigan, Ann Arbor, MI., Schmulbach EL; The Permanente Medical Group, South San Francisco, CA., Reidy-Lagunes DL; Weill Cornell Medical College, New York, NY., Strosberg JR; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., O'Dwyer PJ; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA., Benson AB 3rd; Robert H. Lurie Cancer Center of Northwestern University, Chicago, IL.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Mar 01; Vol. 41 (7), pp. 1359-1369. Date of Electronic Publication: 2022 Oct 19.

Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM).

Autor: Panzuto F; Department of Medical-Surgical Sciences and Translational Medicine, Digestive Disease Unit, Sapienza University of Rome, Sant'Andrea University Hospital, ENETS Center of Excellence, Rome, Italy., Albertelli M; Endocrinology, Department of Internal Medicine and Medical Specialties (DiMI), University of Genova, Genova, Italy.; Endocrinology, IRCCS Ospedale Policlinico San Martino, Genova, Italy., De Rimini ML; Nuclear Medicine - PET and Therapy Unit, Dept. of Health Services AORN dei Colli, Naples, Italy., Rizzo FM; Oncology and Breast Unit, Ospedale 'A. Perrino', Brindisi, Italy., Grana CM; Radiometabolic Therapy, Nuclear Medicine Division, IRCCS IEO European Institute of Oncology, Milano, Italy., Cives M; Interdisciplinary Department of Medicine, University of Bari 'Aldo Moro', Bari, Italy., Faggiano A; Unit of Endocrinology, Department of Clinical and Molecular Medicine, ENETS Center of Excellence, Sant'Andrea Hospital, Sapienza University, Via di Grottarossa 1038, Rome, 00189, Italy. antongiulio.faggiano@uniroma1.it., Versari A; Department of Nuclear Medicine, Azienda Unità Sanitaria Locale-IRCCS of Reggio Emilia, Reggio Emilia, Italy., Tafuto S; Sarcomas and Rare Tumors Unit, Istituto Nazionale Tumori, IRCCS Fondazione 'G. Pascale', Naples, 80131, Italy., Fazio N; Division of Gastrointestinal and Neuroendocrine Tumors Medical Treatment IEO, European Institute of Oncology IRCCS, Milan, Italy., Colao A; Unit of Endocrinology, Diabetology and Andrology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.; UNESCO Chair 'Education for Health and Sustainable Development', University of Naples Federico II, Naples, Italy., Scalorbi F; Nuclear Medicine Department, Foundation IRCCS, Istituto Nazionale Tumori, Milan, Italy., Ferone D; Endocrinology, Department of Internal Medicine and Medical Specialties (DiMI), University of Genova, Genova, Italy.; Endocrinology, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Cinieri S; Oncology and Breast Unit, Ospedale 'A. Perrino', Brindisi, Italy., Maccauro M; Nuclear Medicine Department, Foundation IRCCS, Istituto Nazionale Tumori, Milan, Italy.

Publikováno v: Journal of endocrinological investigation [J Endocrinol Invest] 2024 Oct 12. Date of Electronic Publication: 2024 Oct 12.